No connection

Search Results

ARHS

BEARISH
$7.1 Live
Arhaus, Inc. · NASDAQ
Target $11.12 (+56.6%)
$6.61 52W Range $12.98

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Mar 14, 2026
Market cap
$1.0B
P/E
14.79
ROE
17.7%
Profit margin
4.9%
Debt/Equity
1.39
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
85%
ARHS exhibits weak financial health per the Piotroski F-Score of 4/9, indicating marginal stability with notable red flags in profitability and liquidity. The company trades at a P/E of 14.79, below the sector average of 43.27, but this is misleading given a sharp -28.6% YoY earnings decline and negative Q/Q earnings growth. While the Graham Number ($5.66) suggests undervaluation, the intrinsic value estimate of $3.36 reflects poor growth prospects and deteriorating fundamentals. The lack of dividend, neutral insider activity, and prolonged price decline (down 42.6% over 5 years) further undermine confidence. Despite a recent analyst 'buy' recommendation, the underlying metrics suggest significant distress risk.

Key Strengths

Gross margin of 38.89% indicates strong pricing power and cost control
ROE of 17.65% is above sector average and reflects efficient equity use
Recent quarters have shown strong earnings surprises (avg +32.4% over last 4 quarters)
P/E of 14.79 is below sector average, suggesting potential value on a cyclical basis
Debt/Equity of 1.39 is below sector average (1.65), indicating relatively conservative leverage

Key Risks

Piotroski F-Score of 4/9 signals weak financial health with multiple red flags in profitability and liquidity
Earnings have declined sharply (-28.6% YoY) and Q/Q earnings growth is -29.10%, indicating deteriorating profitability
Quick ratio of 0.57 is critically low, indicating poor short-term liquidity and potential cash flow strain
No Altman Z-Score available, but the combination of low liquidity, declining earnings, and high debt/equity raises bankruptcy risk
Stock has declined 42.6% over 5 years and 34.1% in 6 months, reflecting sustained market skepticism
AI Fair Value Estimate
Based on comprehensive analysis
$3.36
-52.7% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
35
Weak
Value
58
Future
35
Past
48
Health
32
Dividend
0
AI Verdict
weak
Key drivers: Declining earnings and negative growth trends, Low Piotroski F-Score indicating financial instability, Poor liquidity metrics (quick ratio < 0.6), High price decline over 5-year horizon, Lack of dividend and weak insider activity
Confidence
88%
Value
58/100

Ref P/E, PEG, Graham Number

Positives
  • P/E of 14.79 is below sector average of 43.27
  • Price/Sales of 0.73 is low, suggesting potential undervaluation
  • Graham Number of $5.66 is above current price of $7.10, indicating theoretical undervaluation
Watchpoints
  • Intrinsic value estimate of $3.36 is significantly below current price
  • Forward P/E of 12.15 is misleading due to negative earnings base
  • PEG ratio unavailable, but negative earnings growth undermines growth-adjusted valuation
Future
35/100

Ref Growth rates

Positives
  • Recent earnings surprises (avg +32.4%) suggest potential upside in upcoming quarters
  • Positive Q/Q EPS growth of +22.2% in most recent quarter
Watchpoints
  • YoY earnings growth is -28.6%, indicating ongoing profitability contraction
  • Q/Q earnings growth is -29.10%, signaling continued deterioration
  • No forward guidance or clear recovery trajectory evident
Past
48/100

Ref Historical trends

Positives
  • Consistent earnings beat rate of 3/4 in last 4 quarters
  • Historical earnings surprises have been highly positive (e.g., +67.2%, +84.8%)
Watchpoints
  • Long-term price decline of -42.6% over 5 years
  • Persistent negative earnings trends in 2024–2025
  • Declining revenue growth (5.10% YoY) vs. sector average of 7.65%
Health
32/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • ROE of 17.65% is strong and above sector average
  • Debt/Equity of 1.39 is below sector average (1.65)
Watchpoints
  • Piotroski F-Score of 4/9 indicates weak financial health
  • Quick ratio of 0.57 is dangerously low
  • Current ratio of 1.37 is only marginally adequate
  • No Altman Z-Score available, but low liquidity and declining earnings suggest distress risk
Dividend
0/100

Ref Yield, Payout

Positives
No standout positives identified.
Watchpoints
  • No dividend paid or declared
  • Payout ratio is 0.00%
  • Dividend yield is N/A

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$7.1
Analyst Target
$11.12
Upside/Downside
+56.6%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for ARHS and closest competitors.

Updated 2026-03-13
ARH
Arhaus, Inc.
Primary
5Y
-42.6%
3Y
-16.8%
1Y
-18.0%
6M
-34.1%
1M
-27.3%
1W
-7.1%
LQD
Liquidity Services, Inc.
Peer
5Y
+80.5%
3Y
+149.8%
1Y
+9.8%
6M
+34.2%
1M
+14.6%
1W
+3.9%
AXL
American Axle & Manufacturing Holdings, Inc.
Peer
5Y
-9.1%
3Y
-0.5%
1Y
+44.8%
6M
+68.0%
1M
+28.6%
1W
+7.5%
HEP
D-Market Elektronik Hizmetler ve Ticaret A.S.
Peer
5Y
-79.8%
3Y
+135.7%
1Y
+4.2%
6M
+7.5%
1M
-4.2%
1W
+0.4%
LOT
Lotus Technology Inc.
Peer
5Y
-85.4%
3Y
-86.0%
1Y
+5.9%
6M
-28.0%
1M
+27.4%
1W
+27.4%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
14.79
Forward P/E
12.15
PEG Ratio
N/A
P/B Ratio
2.4
P/S Ratio
0.73
EV/Revenue
0.96
EV/EBITDA
9.76
Market Cap
$1.0B

Profitability

Profit margins and return metrics

Profit Margin 4.88%
Operating Margin 5.56%
Gross Margin 38.89%
ROE 17.65%
ROA 4.28%

Growth

Revenue and earnings growth rates

Revenue Growth +5.1%
Earnings Growth -28.6%
Q/Q Revenue Growth N/A
Q/Q Earnings Growth -29.1%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
1.39
Moderate
Current Ratio
1.37
Good
Quick Ratio
0.57
Poor
Cash/Share
$1.82

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-07
$N/A
2026-02-26
$0.11
+17.3% surprise
2025-11-06
$0.09
+12.8% surprise
2025-08-07
$0.25
+67.2% surprise

Consumer Cyclical Sector Comparison

Comparing ARHS against 386 companies in the Consumer Cyclical sector (23 bullish, 133 neutral, 230 bearish)
P/E Ratio
14.79
This Stock
vs
33.98
Sector Avg
-56.5% (Discount)
Return on Equity (ROE)
17.65%
This Stock
vs
-43.92%
Sector Avg
-140.2% (Below Avg)
Profit Margin
4.88%
This Stock
vs
-5.4%
Sector Avg
-190.4% (Weaker)
Debt to Equity
1.39
This Stock
vs
1.51
Sector Avg
-8.2% (Lower)
Revenue Growth
5.1%
This Stock
vs
28.42%
Sector Avg
-82.1% (Slower)
Current Ratio
1.37
This Stock
vs
2.46
Sector Avg
-44.2% (Weaker)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

VELTRI KATHY E
Officer
Stock Award
2026-01-15
10,000 shares
PORTER JENNIFER E
Officer
Stock Award
2026-01-15
10,000 shares
SEDOR CHRISTIAN
Officer
Stock Award
2026-01-15
2,500 shares
VELTRI KATHY E
Officer
Stock Award
2025-11-07
16,667 shares
PORTER JENNIFER E
Officer
Stock Award
2025-11-07
16,667 shares
Insider transactions can signal confidence or concerns about company prospects

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
BUY
13 analysts
Telsey Advisory Group
2026-02-27
Maintains
Market Perform Market Perform
TD Cowen
2026-02-27
Maintains
Buy Buy
Telsey Advisory Group
2026-02-26
Maintains
Market Perform Market Perform
Telsey Advisory Group
2026-02-18
Maintains
Market Perform Market Perform
Morgan Stanley
2026-01-15
Maintains
Equal-Weight Equal-Weight
Telsey Advisory Group
2025-11-07
Maintains
Market Perform Market Perform
Telsey Advisory Group
2025-11-06
Maintains
Market Perform Market Perform
Telsey Advisory Group
2025-10-31
Maintains
Market Perform Market Perform

Past News Coverage

Recent headlines mentioning ARHS from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile